We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App




Ready-To-Use Panels Fulfill CLIA’s Performance Specifications for Assay Verification

By LabMedica International staff writers
Posted on 12 Sep 2023

LGC Clinical Diagnostics (Middlesex, UK) - SeraCare (Milford, MA, USA) has launched its AccuSet HIV Verification Panels - ready-to-use panels designed to fulfill ISO and CLIA’s Performance Specifications for assay verification. More...

The AccuSet HIV Verification Panels are a great tool to help install a new HIV test method and perform assay verification, as well as help evaluate assay performance during development, performing assay validation, and troubleshoot test methods. These panels consist of naturally occurring plasma samples that perfectly mimic patient specimens on laboratory instrumentation. The panels include highly characterized mixed-titer samples that will allow users to efficiently onboard their new assays.

The company offers two HIV Verification Panels to provide labs with options for onboarding both molecular and serological HIV assays based on their specific verification requirements. With the choice of one or both verification panels, labs can tailor their selection to match specific verification protocols. The AccuSet HIV Verification Panels provide the tools labs need to easily meet CLIA’s performance specifications so that users can verify their test system and start reporting patient results.

Related Links:
LGC 
SeraCare 


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.